[시장보고서]윌름스 종양 단백질 시장 : 제품 유형별, 용도별, 최종 사용자별, 검출 방법별, 병기별, 지역별

윌름스 종양 단백질 시장 : 제품 유형별, 용도별, 최종 사용자별, 검출 방법별, 병기별, 지역별

Wilms Tumor Protein Market, By Product Type, By Application, By End User, By Detection Method, By Disease Stage, By Geography

상품코드 : 1741106

리서치사 : Coherent Market Insights

발행일 : 2025년 03월

페이지 정보 : 영문

라이선스 & 가격 (부가세 별도)

US $ 4,500

￦ 6,531,000

Unprintable PDF & Excel (Single User License)

PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 7,000

￦ 10,159,000

PDF & Excel (Multi User License - Up to 7 Users)

PDF & Excel 보고서를 동일 기업 최대 7명까지 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능하며, 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

US $ 10,000

￦ 14,514,000

PDF & Excel (Corporate User License)

PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

윌름스 종양 단백질 시장은 2025년에는 31억 9,000만 달러로 추정되고, 2032년에는 43억 7,000만 달러에 이를 것으로 예측되며, 2025년부터 2032년에 걸쳐 CAGR 4.6%를 나타낼 전망입니다.

보고 범위		보고서 세부정보
기준 연도	2024년	시장 규모(2025년)	31억 9,000만 달러
실적 데이터	2020-2024년	예측 기간	2025-2032년
예측 기간 : 2025-2032년 CAGR :	4.60%	가치 예측(2032년)	43억 7,000만 달러

윌름스 종양 단백질은 다양한 유형의 암 진행에 중요한 역할을 하는 전사 인자입니다. NCBI에 따르면, 윌름스 종양 단백질은 염색질 리모델링 복합체에 관여하고 다수의 유전자 발현을 촉진합니다.

시장 역학 :

세계의 암 환자 증가가 예측 기간 중의 세계의 윌름스 종양 단백질 시장 성장을 가속할 것으로 전망됩니다. 2020년 1월에 발표한 데이터에 의하면, 윌름스 종양은 소아에게 보여지는 신장암의 주류입니다. 미국에서는 매년, 500-600례의 윌름스 종양이 새롭게 보고되고 있어, 이 숫자는 장기간에 걸쳐 비교적 안정된 레벨을 나타내고 있습니다.

그러나 진단과 치료에 드는 비용이 높기 때문에 예측 기간 동안 세계의 윌름스 종양 단백질 시장의 성장이 방해받을 것으로 전망됩니다. 제한된 지역에서는 환자의 접근을 제한 할 수 있습니다.이러한 비용 장벽은 윌름 종양 단백질 관련 치료법 및 진단 방법에 대한 환자의 섭취를 감소시킬 수 있으며, 잠재적으로 시장 확대에 영향을 미치고보다 광범위한 환자 집단에 도달 할 수 있는 능력을 방해할 수 있습니다.

본 조사의 주요 특징

본 보고서에서는 세계의 윌름스 종양 단백질 시장을 상세하게 분석했으며, 2024년을 기준연도로 한 예측 기간(2025-2032년) 시장 규모 및 복합 연간 성장률(CAGR%)을 제공합니다.
또, 다양한 부문에 걸친 잠재적인 수익 기회를 해명해, 이 시장의 매력적인 투자 제안의 매트릭스에 대해서 설명하고 있습니다.
또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시나 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 인사이트도 제공합니다.
기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 파라미터에 근거해, 세계의 윌름스 종양 단백질 시장 주요 기업 프로파일을 제공합니다.
이 보고서로부터의 인사이트은 마케팅 담당자나 기업의 경영진이, 향후 제품 발매, 유형 업그레이드, 시장 확대, 마케팅 전술에 관한 정보에 근거한 의사 결정을 실시하는 것을 가능하게 합니다.
세계의 윌름스 종양 단백질 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통 업체, 신규 진출자, 재무 분석가 등이 업계의 다양한 이해 관계자를 대상으로 합니다.
이해관계자는 세계의 윌름스 종양 단백질 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정이 용이해집니다.

시장 역학
- 성장 촉진요인
윌름스 종양 치료에 있어서의 표적 요법 수요 증가
암 진단 및 치료 분야의 기술 개발
- 성장 억제요인
높은 진단과 치료 비용
- 기회
윌름스 종양의 조사에의 자금 제공 증가
영향 분석
주요 하이라이트
규제 시나리오
제품 출시/승인
PEST 분석
PORTER 분석
합병과 인수 시나리오

제4장 세계의 윌름스 종양 단백질 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

COVID-19 역학
공급측과 수요측의 분석
경제에 미치는 영향

제5장 세계의 윌름스 종양 단백질 시장, 제품 유형별(2020-2032년)

항체
분석 키트
유전자 재조합 단백질
기타

제6장 세계의 윌름스 종양 단백질 시장, 용도별(2020-2032년)

암 진단
암 치료
연구 및 개발
기타

제7장 세계의 윌름스 종양 단백질 시장, 최종 사용자별(2020-2032년)

병원
진단실험실
연구기관
기타

제8장 세계의 윌름스 종양 단백질 시장, 검출 방법별(2020-2032년)

면역조직화학(IHC)
효소 결합 면역 흡착 분석(ELISA)
웨스턴 블로팅
중합효소 연쇄반응(PCR)
기타

제9장 세계의 윌름스 종양 단백질 시장, 병기별(2020-2032년)

진단
모니터링 및 예후

제10장 세계의 윌름스 종양 단백질 시장, 지역별(2020-2032년)

북미
유럽
아시아태평양
라틴아메리카
중동
아프리카

제11장 경쟁 구도

Abcam plc.
Thermo Fisher Scientific, Inc.
Santa Cruz Biotechnology, Inc.
Novus Biologicals, LLC
R&D Systems, Inc.(a subsidiary of Bio-Techne Corporation)
OriGene Technologies, Inc.
Cell Signaling Technology, Inc.
Merck KGaA
BioLegend, Inc.
Genetex, Inc.(a subsidiary of Novus Biologicals, LLC)
Agilent Technologies, Inc.
Proteintech Group, Inc.
Sino Biological Inc.
Boster Biological Technology
Fitzgerald Industries International

제12장 섹션

조사 방법
출판사에 대해

KTH

영문 목차

영문목차

Wilms Tumor Protein Market is estimated to be valued at USD 3.19 Bn in 2025 and is expected to reach USD 4.37 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.6% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 3.19 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	4.60%	2032 Value Projection:	USD 4.37 Bn

Wilms tumor protein is a transcription factor that plays an important role in the progression of various types of cancer. It has also been shown to be associated with resistance to chemotherapies. As a result, Wilms tumor protein has been proposed to be a promising target for the development of new anti-cancer drugs. According to NCBI, Wilms tumor protein is involved in the chromatin remodeling complex and promotes the expression of several genes. It has been shown to interact with several chemotherapeutic agents including daunorubicin and mitoxantrone.

Market Dynamics:

Increasing cancer cases worldwide is expected to drive growth of the global wilms tumor protein market over the forecast period. Moreover, increasing awareness regarding Wilms tumor and its treatment and diagnosis is also expected to propel growth of the global Wilms tumor protein market over the forecast period. According to the data published by American Cancer Society in January 2020, Wilms tumor stands as the predominant form of kidney cancer found in children. Annually, in the U.S., 500 to 600 new Wilms tumor cases are reported, a figure that has exhibited relatively consistent levels over an extended period. Wilms tumors account for approximately 5% of all childhood cancer cases.

However, high cost of diagnosis and treatment procedures is expected to hinder growth of the global Wilms tumor protein market over the forecast period. The high cost of diagnosis and treatment procedures can significantly hinder the growth of the global Wilms tumor protein market. Expensive diagnostic tests and treatments may limit accessibility for patients, particularly in regions with limited healthcare resources. This cost barrier could reduce patient uptake of Wilms tumor protein-related therapies and diagnostics, potentially impacting the market's expansion and inhibiting the ability to reach a broader patient population.

Key features of the study:

This report provides in-depth analysis of the global wilms tumor protein market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global wilms tumor protein market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Abcam plc, Thermo Fisher Scientific, Inc., Santa Cruz Biotechnology, Inc., Novus Biologicals, LLC, R&D Systems, Inc. (a subsidiary of Bio-Techne Corporation), OriGene Technologies, Inc., Cell Signaling Technology, Inc., Merck KGaA, BioLegend, Inc., Genetex, Inc. (a subsidiary of Novus Biologicals, LLC), Agilent Technologies, Inc., Proteintech Group, Inc., Sino Biological Inc., Boster Biological Technology, and Fitzgerald Industries International
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global wilms tumor protein market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global wilms tumor protein market

Global Wilms Tumor Protein Market Detailed Segmentation:

By Product Type:
- Antibodies
- Assay Kits
- Recombinant Proteins
- Others
By Application:
- Cancer Diagnosis
- Cancer Treatment
- Research and Development
- Others
By End User:
- Hospitals
- Diagnostic Laboratories
- Research Institutes
- Others
By Detection Method:
- Immunohistochemistry (IHC)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Western Blotting
- Polymerase Chain Reaction (PCR)
- Others
By Disease Stage:
- Diagnosis
- Monitoring and Prognosis
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Abcam plc
- Thermo Fisher Scientific, Inc.
- Santa Cruz Biotechnology, Inc.
- Novus Biologicals, LLC
- R&D Systems, Inc. (a subsidiary of Bio-Techne Corporation)
- OriGene Technologies, Inc.
- Cell Signaling Technology, Inc.
- Merck KGaA
- BioLegend, Inc.
- Genetex, Inc. (a subsidiary of Novus Biologicals, LLC)
- Agilent Technologies, Inc.
- Proteintech Group, Inc.
- Sino Biological Inc.
- Boster Biological Technology
- Fitzgerald Industries International

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Wilms Tumor Protein, By Product Type
- Market Wilms Tumor Protein, By Application
- Market Wilms Tumor Protein, By End User
- Market Wilms Tumor Protein, By Detection Method
- Market Wilms Tumor Protein, By Disease Stage
- Market Wilms Tumor Protein, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing demand for targeted therapies for Wilms tumor treatment
Technological developments in the field of cancer diagnostics and treatment
- Restraints
High cost of diagnosis and treatment procedures
- Opportunities
Growing funding for research on Wilms tumor
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Wilms Tumor Protein Market- Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Wilms Tumor Protein Market, By Product Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Assay Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Recombinant Proteins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Wilms Tumor Protein Market, By Application, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Cancer Diagnosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Cancer Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Research and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Wilms Tumor Protein Market, By End User, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Wilms Tumor Protein Market, By Detection Method, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Immunohistochemistry (IHC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,( US$ Bn)
Enzyme-Linked Immunosorbent Assay (ELISA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Western Blotting
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Polymerase Chain Reaction (PCR)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

9. Global Wilms Tumor Protein Market, By Disease Stage, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Diagnosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Monitoring and Prognosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

10. Global Wilms Tumor Protein Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2025-2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2020-2032, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-Region, 2020-2032, (US$ Bn)
  - North Africa
  - Central Africa
  - South Africa

11. Competitive Landscape

Abcam plc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Santa Cruz Biotechnology, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Novus Biologicals, LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
R&D Systems, Inc. (a subsidiary of Bio-Techne Corporation)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
OriGene Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Cell Signaling Technology, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
BioLegend, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Genetex, Inc. (a subsidiary of Novus Biologicals, LLC)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Agilent Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Proteintech Group, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Sino Biological Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Boster Biological Technology
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Fitzgerald Industries International
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

12. Section

Research Methodology
About us